EssilorLuxottica's recommendation from UBS has been downgraded from 'buy' to 'neutral', despite an increase in the price target from 232 to 248 euros. This suggests a potential upside of around 7% for the company's shares.
UBS acknowledges the positive prospects for sales acceleration but expresses concerns about high valuations and potential risks, such as customs tariffs. UBS advises investors to approach with caution and take a pause to reassess the situation surrounding the Franco-Italian optical giant. The firm emphasizes the importance of being aware of market dynamics when navigating the investment landscape.